Bayer Aktiengesellschaft (BIT:1BAYN)

Italy flag Italy · Delayed Price · Currency is EUR
45.48
-0.52 (-1.13%)
Last updated: Feb 13, 2026, 3:10 PM CET
Market Cap44.89B +111.1%
Revenue (ttm)45.87B -1.9%
Net Income-198.00M
EPS-0.20
Shares Outn/a
PE Ration/a
Forward PE9.15
Dividend0.11 (0.24%)
Ex-Dividend DateApr 28, 2025
Volume14,810
Average Volume37,693
Open45.48
Previous Close46.00
Day's Range45.35 - 45.73
52-Week Range18.44 - 46.86
Beta0.97
RSI62.43
Earnings DateFeb 25, 2026

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin... [Read more]

Sector Healthcare
Founded 1863
Employees 88,502
Stock Exchange Borsa Italiana
Ticker Symbol 1BAYN
Full Company Profile

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial Statements